The tissue microarray market size has grown rapidly in recent years. It will grow from $13.11 billion in 2025 to $14.68 billion in 2026 at a compound annual growth rate (CAGR) of 12%. The growth in the historic period can be attributed to growing cancer research activities, increasing adoption of immunohistochemistry techniques, expansion of academic pathology research, rising demand for biomarker validation tools, availability of paraffin-embedded tissue samples.
The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $23.61 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing investments in precision oncology research, rising adoption of digital pathology solutions, expansion of translational research initiatives, growing demand for multi-omics analysis, increasing use of tissue microarrays in drug discovery. Major trends in the forecast period include increasing use of high-throughput tissue analysis platforms, rising adoption of multiplex immunohistochemistry, growing demand for standardized tissue arrays, expansion of automated tissue microarray construction, enhanced integration with molecular diagnostics.
The growing demand for personalized medicine is expected to drive growth in the tissue microarray market in the coming years. Personalized medicine customizes medical treatment based on individual patient characteristics to deliver more precise and effective care. Tissue microarrays are used in personalized medicine to analyze multiple tissue samples simultaneously, enabling rapid and efficient biomarker assessment for tailored patient treatments. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the US FDA approved 16 new personalized treatments for rare disease patients in 2023, up significantly from six approvals in 2022. Thus, the growing demand for personalized medicine is fueling growth in the tissue microarray market.
Major companies operating in the tissue microarray market are focusing on advanced solutions, such as microarray platforms to enhance precision and efficiency in high-throughput tissue analysis. A microarray platform is a technology that allows for simultaneous analysis of multiple genes or other biomolecules on a small surface, facilitating genetic and expression studies. For instance, in June 2023, MARGenomics, a Spain-based hospital del Mar medical research institute, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform funded by the Carlos III Health Institute (ISCIII) and the European Union's NextGenerationEU initiative. It is the inaugural microarray platform in both Europe and the United States to receive regulatory approval for diagnostic purposes, attaining IVD-R (In Vitro Diagnosis Regulation) certification. The system boasts diverse functionalities, encompassing genomic and expression microarrays.
In May 2024, Bruker Corporation, a US-based provider of high-performance scientific instruments and analytical solutions, acquired NanoString Technologies for approximately USD 392.6 million. Through this acquisition, Bruker aims to expand its spatial biology and transcriptomics capabilities, strengthen its position in high-plex tissue analysis, and enhance its technology portfolio for advanced tissue-based and translational research workflows. NanoString Technologies, also US-based, provides spatial transcriptomics, single-cell imaging, and gene-expression analysis platforms widely used in whole-tissue and tissue-microarray research applications.
Major companies operating in the tissue microarray market are BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.
North America was the largest region in the tissue microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tissue microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the tissue microarray market by increasing costs of imported laboratory instruments, microarray construction systems, reagents, and imaging equipment. Research institutions and pharmaceutical companies in North America and Europe are most affected due to dependence on imported precision tools, while Asia-Pacific faces higher costs for advanced research infrastructure. These tariffs are raising operational expenses and slowing laboratory upgrades. At the same time, they are supporting domestic production of laboratory equipment and fostering regional research supply chains.
The tissue microarray market research report is one of a series of new reports that provides tissue microarray market statistics, including tissue microarray industry global market size, regional shares, competitors with a tissue microarray market share, detailed tissue microarray market segments, market trends and opportunities, and any further data you may need to thrive in the tissue microarray industry. This tissue microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A tissue microarray is a high-throughput technology that enables comprehensive analysis of antigen expression across numerous tissues and cells in a single experiment, typically using paraffin blocks or formalin. It allows for the simultaneous assessment of protein expression in multiple tissue samples.
The primary types of tissue microarrays include immunohistochemistry, fluorescent in situ hybridization, frozen tissue array, and other variants. Immunohistochemistry (IHC) is a technique used to diagnose certain types of cancer, such as mesothelioma, by employing a visual marker to locate antigens in biopsy tissue. Various technologies such as DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, western blotting, and others are utilized for applications in oncology, gene expression profiling, single nucleotide polymorphism (SNP) detection, double-stranded B-DNA microarrays, comparative genomic hybridization, sequencing bioinformatics, and more. These technologies find applications across different end-users, including pharmaceutical and biotechnological companies, research organizations, and hospitals.
The tissue microarray market consists of sales of molds, needles, and tissue punches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $23.61 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing investments in precision oncology research, rising adoption of digital pathology solutions, expansion of translational research initiatives, growing demand for multi-omics analysis, increasing use of tissue microarrays in drug discovery. Major trends in the forecast period include increasing use of high-throughput tissue analysis platforms, rising adoption of multiplex immunohistochemistry, growing demand for standardized tissue arrays, expansion of automated tissue microarray construction, enhanced integration with molecular diagnostics.
The growing demand for personalized medicine is expected to drive growth in the tissue microarray market in the coming years. Personalized medicine customizes medical treatment based on individual patient characteristics to deliver more precise and effective care. Tissue microarrays are used in personalized medicine to analyze multiple tissue samples simultaneously, enabling rapid and efficient biomarker assessment for tailored patient treatments. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the US FDA approved 16 new personalized treatments for rare disease patients in 2023, up significantly from six approvals in 2022. Thus, the growing demand for personalized medicine is fueling growth in the tissue microarray market.
Major companies operating in the tissue microarray market are focusing on advanced solutions, such as microarray platforms to enhance precision and efficiency in high-throughput tissue analysis. A microarray platform is a technology that allows for simultaneous analysis of multiple genes or other biomolecules on a small surface, facilitating genetic and expression studies. For instance, in June 2023, MARGenomics, a Spain-based hospital del Mar medical research institute, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform funded by the Carlos III Health Institute (ISCIII) and the European Union's NextGenerationEU initiative. It is the inaugural microarray platform in both Europe and the United States to receive regulatory approval for diagnostic purposes, attaining IVD-R (In Vitro Diagnosis Regulation) certification. The system boasts diverse functionalities, encompassing genomic and expression microarrays.
In May 2024, Bruker Corporation, a US-based provider of high-performance scientific instruments and analytical solutions, acquired NanoString Technologies for approximately USD 392.6 million. Through this acquisition, Bruker aims to expand its spatial biology and transcriptomics capabilities, strengthen its position in high-plex tissue analysis, and enhance its technology portfolio for advanced tissue-based and translational research workflows. NanoString Technologies, also US-based, provides spatial transcriptomics, single-cell imaging, and gene-expression analysis platforms widely used in whole-tissue and tissue-microarray research applications.
Major companies operating in the tissue microarray market are BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.
North America was the largest region in the tissue microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the tissue microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the tissue microarray market by increasing costs of imported laboratory instruments, microarray construction systems, reagents, and imaging equipment. Research institutions and pharmaceutical companies in North America and Europe are most affected due to dependence on imported precision tools, while Asia-Pacific faces higher costs for advanced research infrastructure. These tariffs are raising operational expenses and slowing laboratory upgrades. At the same time, they are supporting domestic production of laboratory equipment and fostering regional research supply chains.
The tissue microarray market research report is one of a series of new reports that provides tissue microarray market statistics, including tissue microarray industry global market size, regional shares, competitors with a tissue microarray market share, detailed tissue microarray market segments, market trends and opportunities, and any further data you may need to thrive in the tissue microarray industry. This tissue microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A tissue microarray is a high-throughput technology that enables comprehensive analysis of antigen expression across numerous tissues and cells in a single experiment, typically using paraffin blocks or formalin. It allows for the simultaneous assessment of protein expression in multiple tissue samples.
The primary types of tissue microarrays include immunohistochemistry, fluorescent in situ hybridization, frozen tissue array, and other variants. Immunohistochemistry (IHC) is a technique used to diagnose certain types of cancer, such as mesothelioma, by employing a visual marker to locate antigens in biopsy tissue. Various technologies such as DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, western blotting, and others are utilized for applications in oncology, gene expression profiling, single nucleotide polymorphism (SNP) detection, double-stranded B-DNA microarrays, comparative genomic hybridization, sequencing bioinformatics, and more. These technologies find applications across different end-users, including pharmaceutical and biotechnological companies, research organizations, and hospitals.
The tissue microarray market consists of sales of molds, needles, and tissue punches. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Tissue Microarray Market Characteristics
3. Tissue Microarray Market Supply Chain Analysis
4. Global Tissue Microarray Market Trends and Strategies
5. Tissue Microarray Market Analysis of End Use Industries
7. Global Tissue Microarray Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Tissue Microarray Total Addressable Market (TAM) Analysis for the Market
9. Tissue Microarray Market Segmentation
10. Tissue Microarray Market Regional and Country Analysis
11. Asia-Pacific Tissue Microarray Market
12. China Tissue Microarray Market
13. India Tissue Microarray Market
14. Japan Tissue Microarray Market
15. Australia Tissue Microarray Market
16. Indonesia Tissue Microarray Market
17. South Korea Tissue Microarray Market
18. Taiwan Tissue Microarray Market
19. South East Asia Tissue Microarray Market
20. Western Europe Tissue Microarray Market
21. UK Tissue Microarray Market
22. Germany Tissue Microarray Market
23. France Tissue Microarray Market
24. Italy Tissue Microarray Market
25. Spain Tissue Microarray Market
26. Eastern Europe Tissue Microarray Market
27. Russia Tissue Microarray Market
28. North America Tissue Microarray Market
29. USA Tissue Microarray Market
30. Canada Tissue Microarray Market
31. South America Tissue Microarray Market
32. Brazil Tissue Microarray Market
33. Middle East Tissue Microarray Market
34. Africa Tissue Microarray Market
36. Tissue Microarray Market Competitive Landscape and Company Profiles
37. Tissue Microarray Market Other Major and Innovative Companies
40. Tissue Microarray Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Tissue Microarray Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses tissue microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for tissue microarray? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue microarray market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Immunohistochemistry; Fluorescent In Situ Hybridization; Frozen Tissue Array; Other Types2) By Technology: Immunohistochemistry (IHC)-Based Detection; In Situ Hybridization (ISH) Technologies; Digital Pathology and Image Analysis; Tissue Microarray Construction Technologies; Signal Detection and Visualization Technologies
3) By Application: Oncology Research and Biomarker Validation; Drug Discovery and Development; Translational and Clinical Research; Protein Expression and Localization Analysis; Gene and RNA Expression Analysis (Tissue-Based); Comparative Pathology and Toxicology Studies
4) By End-User: Pharmaceutical And Biotechnological Companies; Research Organizations; Hospitals
Subsegments:
1) By Immunohistochemistry: Automated Immunohistochemistry; Manual Immunohistochemistry; Multiplex Immunohistochemistry2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH; Multi-Color FISH; DNA FISH
3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples; Snap-Frozen Tissue Array
4) By Other Types: RNA In Situ Hybridization; Paraffin-Embedded Tissue Array
Companies Mentioned: BioIVT LLC; BioChain Institute Inc.; Creative Bioarray Co.; 3DHISTECH Ltd.; OriGene Technologies Inc.; Bio SB Inc.; ProteoGenex Inc.; US Biomax Inc.; AMS Biotechnology Ltd.; TissueArray.Com LLC; Pantomics Inc.; Zyagen Inc.; Asterand Bioscience; Indivumed GmbH; PrecisionMed Inc.; Conversant Bio AB; RayBiotech Life Inc.; Novus Biologicals LLC; Tristar Group; iSpecimen Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Tissue Microarray market report include:- BioIVT LLC
- BioChain Institute Inc.
- Creative Bioarray Co.
- 3DHISTECH Ltd.
- OriGene Technologies Inc.
- Bio SB Inc.
- ProteoGenex Inc.
- US Biomax Inc.
- AMS Biotechnology Ltd.
- TissueArray.Com LLC
- Pantomics Inc.
- Zyagen Inc.
- Asterand Bioscience
- Indivumed GmbH
- PrecisionMed Inc.
- Conversant Bio AB
- RayBiotech Life Inc.
- Novus Biologicals LLC
- Tristar Group
- iSpecimen Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 14.68 Billion |
| Forecasted Market Value ( USD | $ 23.61 Billion |
| Compound Annual Growth Rate | 12.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
